Publications by authors named "Suzanne Fanning"

Claim this Profile
O
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis.
Lori A Leslie, John H Baird, Ian W Flinn, Michael Tees, Daanish Hoda, Suzanne Fanning

Am J Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study.
Alison Sehgal, Daanish Hoda, Peter A Riedell, Nilanjan Ghosh, Mehdi Hamadani, Suzanne Fanning

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.
Yuliya Linhares, Cesar O Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris, Suzanne Fanning

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.
Daria V Babushok, Amy E DeZern, Carlos M de Castro, Zora R Rogers, David Beenhouwer, Suzanne R Fanning

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.
Sudhir Manda, Bertrand M Anz, Christopher Benton, E Randolph Broun, Habte A Yimer, Suzanne Fanning

Hematol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Alison Sehgal, Daanish Hoda, Peter A Riedell, Nilanjan Ghosh, Mehdi Hamadani, Suzanne Fanning

Lancet Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and Ultrastructural Analysis of the Multiple Myeloma Cell Niche and a Patient-Specific Model of Plasma Cell Dysfunction.
Katrina A Harmon, Sara Roman, Harrison D Lancaster, Saeeda Chowhury, Elizabeth Cull, Suzanne Fanning

Microsc Microanal· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
Mohamed A Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori, Suzanne Fanning

Transplant Cell Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.
Zachariah DeFilipp, Anjali S Advani, Veronika Bachanova, Ryan D Cassaday, Daniel J Deangelo, Suzanne Fanning

Biol Blood Marrow Transplant· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Shahrukh K Hashmi, Stephanie J Lee, Bipin N Savani, Linda Burns, John R Wingard, Suzanne Fanning

Biol Blood Marrow Transplant· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial.
Jeff P Sharman, Charles M Farber, Daruka Mahadevan, Marshall T Schreeder, Heather D Brooks, Suzanne Fanning

Br J Haematol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.
Luciano J Costa, Suzanne R Fanning, Joe Stephenson, Lawrence B Afrin, Emily Kistner-Griffin

Leuk Lymphoma· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
Michael Wang, Leslie L Popplewell, Robert H Collins, Jane N Winter, Andre Goy, Suzanne R Fanning

Br J Haematol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma.
Rachid Baz, Suzanne Fanning, Lori Kunkel, Sameh Gaballa, Mary Ann Karam

Leuk Lymphoma· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis